We are live on
!
Find out more
PCM
Prelude Capital Management Portfolio holdings
AUM
$1.31B
1-Year Est. Return
62.02%
This Fund
S&P 500
This Quarter
Est. Return
+31.28%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.82B
AUM Growth
+$324M
(+22%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-6.62%
Top 10 Holdings %
Top 10 Hldgs %
36.31%
Holding
2,419
New
1,036
Increased
430
Reduced
305
Closed
497
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
|
+$24M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$7.59M |
| 3 |
CZR
Caesars Entertainment Corporation
CZR
|
+$5.85M |
| 4 |
Broadcom
AVGO
|
+$5.1M |
| 5 |
ACIA
Acacia Communications Inc
ACIA
|
+$3.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$16.1M |
| 2 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$11.4M |
| 3 |
FTSV
Forty Seven, Inc. Common Stock
FTSV
|
+$11.3M |
| 4 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$10.3M |
| 5 |
Micron Technology
MU
|
+$8.71M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.98% |
| 2 | Consumer Discretionary | 5.02% |
| 3 | Healthcare | 3.42% |
| 4 | Financials | 2.97% |
| 5 | Industrials | 2.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Union Pacific
UNP
$174B
| $734K | 0.04% |
+4,339
| New | +$695K |
|
377
FirstEnergy
FE
$27.5B
| $733K | 0.04% |
18,904
+16,015
| +554% | +$662K |
|
378
iShares Core Dividend Growth ETF
DGRO
$43.6B
| $732K | 0.04% |
19,478
-519
| -3% | -$18.9K |
|
379
Dick's Sporting Goods
DKS
$18.7B
| $732K | 0.04% |
+17,735
| New | +$563K |
|
380
Vanguard FTSE Europe ETF
VGK
$31.1B
| $730K | 0.04% |
+14,501
| New | +$684K |
|
381
Freeport-McMoran
FCX
$97.5B
| $729K | 0.04% |
+63,008
| New | +$577K |
|
|
IPHI
382
DELISTED
INPHI CORPORATION
IPHI
| $727K | 0.04% |
6,186
-18,374
| -75% | -$1.93M |
|
|
IMMU
383
DELISTED
Immunomedics Inc
IMMU
| $727K | 0.04% |
+20,523
| New | +$600K |
|
|
NOA
384
North American Construction
NOA
$395M
| $726K | 0.04% |
115,998
| – | – |
|
385
TransUnion
TRU
$15.3B
| $723K | 0.04% |
8,311
+5,016
| +152% | +$400K |
|
386
CALL
CoStar Group
CSGP
$12.3B
| $711K | 0.04% |
10,000
+4,000
| +67% | +$259K |
|
387
ConocoPhillips
COP
$141B
| $705K | 0.04% |
16,783
+3,090
| +23% | +$125K |
|
388
CALL
Marvell Technology
MRVL
$196B
| $701K | 0.04% |
+20,000
| New | +$586K |
|
389
Dr. Reddy's Laboratories
RDY
$10.2B
| $700K | 0.04% |
+66,000
| New | +$671K |
|
390
CALL
AbbVie
ABBV
$435B
| $697K | 0.04% |
7,100
-400
| -5% | -$35.2K |
|
391
PUT
Macy's
M
$6.68B
| $694K | 0.04% |
+100,800
| New | +$621K |
|
392
Edison International
EIX
$26.4B
| $683K | 0.04% |
+12,582
| New | +$724K |
|
393
APi Group
APG
$18B
| $681K | 0.04% |
+84,110
| New | +$636K |
|
394
CALL
Berkshire Hathaway Class B
BRK.B
$1.13T
| $678K | 0.04% |
3,800
+3,400
| +850% | +$621K |
|
395
Amneal Pharmaceuticals
AMRX
$5.79B
| $675K | 0.04% |
141,842
-75,000
| -35% | -$309K |
|
396
Herbalife
HLF
$1.29B
| $672K | 0.04% |
+14,945
| New | +$580K |
|
397
UnitedHealth
UNH
$370B
| $670K | 0.04% |
+2,273
| New | +$651K |
|
398
PUT
Qualys
QLYS
$6.35B
| $655K | 0.04% |
+6,300
| New | +$660K |
|
399
Zimmer Biomet
ZBH
$18.4B
| $653K | 0.04% |
+5,637
| New | +$650K |
|
400
Century Communities
CCS
$2.03B
| $652K | 0.04% |
21,270
-1,565
| -7% | -$37.4K |
|
Similar funds
PFBT
CCP
SP
HCS
SPC
GPCM
MCM
CC
Prelude Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Prelude Capital Management held 2,419 positions worth $1.82B, up 22% from $1.49B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Prelude Capital Management withdrew a net $120M in Q2 2020, closing 497 positions and reducing 305 holdings. Its most notable exit was Allergan plc, an estimated $16.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7% of assets, up from 6.3% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Prelude Capital Management opened a new position in iShares 0-5 Year High Yield Corporate Bond ETF worth $24.4M.
- Prelude Capital Management's largest Q2 2020 buy was iShares 0-5 Year High Yield Corporate Bond ETF: 568,440 shares worth $24.4M.
- Prelude Capital Management added most to Acacia Communications Inc in Q2 2020, an estimated $3.72M increase.
- Prelude Capital Management's biggest Q2 2020 reduction was Micron Technology, cutting an estimated $8.71M.
- Prelude Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $16.1M.
- Prelude Capital Management's ten largest holdings make up 36% of its $1.82B portfolio in Q2 2020.
- Prelude Capital Management opened 1,036 new positions and closed 497 in Q2 2020.
- Prelude Capital Management's portfolio value rose 22% quarter-over-quarter to $1.82B.
Based on Prelude Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.